Barely Significant
← all excerpts

Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome.

J Cancer · 2020 · PMC7646181 · PMID 33193888

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

showed a trendp =0.07so close (0.05 < p ≤ 0.1)
In the basal breast cancer subtype, PD-L1 expression on stromal immune cells showed a trend toward improved prognosis (HR=0.074, 95% CI=0.004-1.234, p =0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.